IP Library Granted Patent US 7,422,876
Granted Patent B2
US 7,422,876 · App. 11/034,411 · Granted Sep 9, 2008

Methods for generating cellulases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,422,876
App. No.
11/034,411
Granted
Sep 9, 2008
Kind
B2
Abstract

The invention relates to carboxymethyl cellulases and to polynucleotides encoding the carboxymethyl cellulases. In addition methods of designing new carboxymethyl cellulases and method of use thereof are also provided. The carboxymethyl cellulases have increased activity and stability at increased pH and temperature.

Claims (38)

1. A method of generating a nucleic acid encoding a cellulase comprising:

(a) providing a template nucleic acid encoding a polypeptide having cellulase activity comprising (i) a nucleic acid sequence having at least 90% sequence identity to SEQ ID NO:1, (ii) a nucleic acid sequence encoding a polypeptide, wherein the polypeptide has at least 90% sequence identity to SEQ ID NO:2, (iii) a nucleic acid that hybridizes under high stringency conditions to the complement of the nucleic acid of SEQ ID NO:1 (iv) a nucleic acid that hybridizes under high stringency conditions to the complement of a nucleic acid encoding a polypeptide, wherein the polypeptide has the sequence of SEQ ID NO:2, or, (v) sequences complementary to (i), (ii), (iii), or (iv);

(b) varying the template nucleic acid of (a) by modifying one or more nucleotides in said sequence to another nucleotide, deleting one or more nucleotides in said sequence, or adding one or more nucleotides to said sequence, thereby generating a variant nucleic acid encoding a cellulase; and

(c) selecting a variant nucleic acid that encodes a cellulase, thereby generating a nucleic acid encoding a cellulase.

2. The method of claim 1 , wherein the modifications, deletions or additions are introduced by a method selected from the group consisting of error-prone PCR, shuffling, oligonucleotide-directed mutagenesis, assembly PCR, sexual PCR mutagenesis, in vivo mutagenesis, cassette mutagenesis, recursive ensemble mutagenesis, exponential ensemble mutagenesis, site-specific mutagenesis, gene reassembly, Gene Site Saturation Mutagenesis (GSSM) and any combination thereof.

3. The method of claim 1 , wherein the modifications, deletions or additions are introduced by error-prone PCR.

4. The method of claim 1 , wherein the modifications, deletions or additions are introduced by shuffling.

5. The method of claim 1 , wherein the modifications, deletions or additions are introduced by oligonucleotide-directed mutagenesis.

6. The method of claim 1 , wherein the modifications, deletions or additions are introduced by assembly PCR.

7. The method of claim 1 , wherein the modifications, deletions or additions are introduced by sexual PCR mutagenesis.

8. The method of claim 1 , wherein the modifications, deletions or additions are introduced by in vivo mutagenesis.

9. The method of claim 1 , wherein the modifications, deletions or additions are introduced by cassette mutagenesis.

10. The method of claim 1 , wherein the modifications, deletions or additions are introduced by recursive ensemble mutagenesis.

11. The method of claim 1 , wherein the modifications, deletions or additions are introduced by exponential ensemble mutagenesis.

12. The method of claim 1 , wherein the modifications, deletions or additions are introduced by site-specific mutagenesis.

13. The method of claim 1 , wherein the modifications, deletions or additions are introduced by gene reassembly.

14. The method of claim 1 , wherein the modifications, deletions or additions are introduced by Gene Site Saturation Mutagenesis (GSSM).

15. The method of claim 1 , wherein the sequence identity is at least 95% sequence identity.

16. The method of claim 1 , wherein the sequence identity is at least 97% sequence identity.

17. The method of claim 16 , wherein the nucleic acid has the sequence of SEQ ID NO:1 or encodes a polypeptide having the sequence of SEQ ID NO:2.

18. A method of generating a cellulase comprising:

(a) providing a template nucleic acid encoding a polypeptide having cellulase activity comprising (i) a nucleic acid sequence having at least 90% sequence identity to SEQ ID NO:1, (ii) a nucleic acid sequence encoding a polypeptide, wherein the polypeptide has at least 90% sequence identity to SEQ ID NO:2, (iii) a nucleic acid that hybridizes under high stringency conditions to the complement of the nucleic acid (iv) a nucleic acid that hybridizes under high stringency conditions to the complement of a nucleic acid encoding a polypeptide, wherein the polypeptide has the sequence of SEQ ID NO:2, or, (v) sequences complementary to (i), (ii), (iii), or (iv);

(b) varying the template nucleic acid of (a) by modifying one or more nucleotides in the sequence to another nucleotide, deleting one or more nucleotides in the sequence, or adding one or more nucleotides to the sequence of (a), thereby generating a variant nucleic acid encoding a cellulase; and

(c) expressing the variant nucleic acid and testing the expressed polypeptide for cellulase activity, thereby generating a nucleic acid encoding a cellulase.

19. A method of making a variant of a nucleic acid encoding a cellulase comprising:

(a) providing a template nucleic acid encoding a polypeptide having cellulase activity comprising (i) a nucleic acid sequence having at least 90% sequence identity to SEQ ID NO:1, (ii) a nucleic acid sequence encoding a polypeptide, wherein the polypeptide has at least 90% sequence identity to SEQ ID NO:2, (iii) a nucleic acid that hybridizes under high stringency conditions to the complement of the nucleic acid of SEQ ID NO: 1 (iv) a nucleic acid that hybridizes under high stringency conditions to the complement of a nucleic acid encoding a polypeptide, wherein the polypeptide has the sequence of SEQ ID NO:2, or, (v) sequences complementary to (i), (ii), (iii), or (iv); and

(b) making a variant sequence of (a) by modifying one or more nucleotides in the sequence to another nucleotide, deleting one or more nucleotides in the sequence, or adding one or more nucleotides to the sequence of (a).

20. The method of claim 18 , wherein the modifications, deletions or additions are introduced by a method selected from the group consisting of error-prone PCR, shuffling, oligonucleotide-directed mutagenesis, assembly PCR, sexual PCR mutagenesis, in vivo mutagenesis, cassette mutagenesis, recursive ensemble mutagenesis, exponential ensemble mutagenesis, site-specific mutagenesis, gene reassembly, Gene Site Saturation Mutagenesis (GSSM) and any combination thereof.

21. The method of claim 19 , wherein the modifications, deletions or additions are introduced by a method selected from the group consisting of error-prone PCR, shuffling, oligonucleotide-directed mutagenesis, assembly PCR, sexual PCR mutagenesis, in vivo mutagenesis, cassette mutagenesis, recursive ensemble mutagenesis, exponential ensemble mutagenesis, site-specific mutagenesis, gene reassembly, Gene Site Saturation Mutagenesis (GSSM) and any combination thereof.

22. The method of claim 1 , wherein the method is iteratively repeated.

23. The method of claim 18 , wherein the method is iteratively repeated.

24. The method of claim 19 , wherein the method is iteratively repeated.

25. The method of claim 1 , wherein the polypeptide encoded by the variant nucleic acid has cellulase activity at a temperature, pH or salinity level that is different from that of the polypeptide encoded by the template nucleic acid.

26. The method of claim 18 , wherein the polypeptide encoded by the variant nucleic acid has cellulase activity at a temperature, pH or salinity level that is different from that of the polypeptide encoded by the template nucleic acid.

27. The method of claim 19 , wherein the polypeptide encoded by the variant nucleic acid has cellulase activity at a temperature, pH or salinity level that is different from that of the polypeptide encoded by the template nucleic acid.

28. The method of claim 1 , wherein the polypeptide encoded by the variant nucleic acid has a cellulase activity that has a different stereo-, regio- or chemo-selectivity from that of the polypeptide encoded by the template nucleic acid.

29. The method of claim 18 , wherein the polypeptide encoded by the variant nucleic acid has a cellulase activity at a temperature, pH or salinity level that is different from that of the polypeptide encoded by the template nucleic acid.

30. The method of claim 19 , wherein the polypeptide encoded by the variant nucleic acid has a cellulase activity at a temperature, pH or salinity level that is different from that of the polypeptide encoded by the template nucleic acid.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jan 9, 2014
From: ATHYRIUM OPPORTUNITIES FUND (A) LP
To: VERENIUM CORPORATION
Reel/Frame 031956/0016 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 11, 2012
From: VERENIUM CORPORATION
To: ATHYRIUM OPPORTUNITIES FUND (A) LP
Reel/Frame 029444/0119 →
RELEASE OF SECURITY INTEREST Recorded Jun 1, 2012
From: COMERICA BANK
To: VERENIUM CORPORATION
Reel/Frame 028300/0200 →
SECURITY AGREEMENT Recorded Oct 21, 2011
From: VERENIUM CORPORATION, A DELAWARE CORPORATION
To: COMERICA BANK, A TEXAS BANKING ASSOCIATION
Reel/Frame 027099/0408 →
CHANGE OF NAME Recorded Nov 19, 2007
From: DIVERSA CORPORATION
To: VERENIUM CORPORATION
Reel/Frame 020134/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2005
From: SHORT, JAY M.; MATHUR, ERIC J.; LAM, DAVID E.
To: DIVERSA CORPORATION
Reel/Frame 015889/0348 →